Quest Diagnostics
DGX
$139.70
Share price
-0.25%
Change (1 day)
-3.59%
Change (1 year)
Categories
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.
Quest Diagnostics (DGX) Fails to deliver data
Key failure to deliver metrics for Quest Diagnostics :
- Last SEC data release: 2023-02-28
- Last 15 days FTD volume: $0 M
- Last 3 months FTD volume: $0.76 M
- Last year FTD volume: $26.17 M
Failures to deliver for Quest Diagnostics (DGX) - 3 month history
Number of shares, 3 month chartBiweekly Failures to deliver volume for Quest Diagnostics (DGX) - since 2013
Volume in USD (price x number of shares), data since 2013Quest Diagnostics (DGX) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2023 | $0.3 M | -98.92% |
| 2022 | $27.85 M | -61.47% |
| 2021 | $72.29 M | 119.6% |
| 2020 | $32.92 M | -59.04% |
| 2019 | $80.37 M | 47.27% |
| 2018 | $54.57 M | 197.07% |
| 2017 | $18.37 M | -60.99% |
| 2016 | $47.09 M | 14.17% |
| 2015 | $41.25 M | -56.86% |
| 2014 | $95.62 M | 66.88% |
| 2013 | $57.3 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 LabCorp LH | $4.99 M | $0.12 B | 🇺🇸 USA |
 Translate Bio
TBIO.defunct | $0.05 M | $13.8 M | 🇺🇸 USA |
 Psychemedics PMD | $0 M | $0.01 M | 🇺🇸 USA |
 NeoGenomics
NEO | $5.94 M | $11.54 M | 🇺🇸 USA |
 Qiagen QGEN | $7.84 M | $82.97 M | 🇳🇱 Netherlands |
 Enzo Biochem ENZ | $0.02 M | $0.18 M | 🇺🇸 USA |